These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 19368633

  • 1. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y, Sollano JD, Farrell GC.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [Abstract] [Full Text] [Related]

  • 2. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E, Bergk A, Berg T.
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [Abstract] [Full Text] [Related]

  • 3. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [Abstract] [Full Text] [Related]

  • 4. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG, Mohammed R, Yuen MF, Kao JH.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Takemura S, Shiomi S, Kinoshita H.
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [Abstract] [Full Text] [Related]

  • 6. Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.
    Masuzaki R, Yoshida H, Omata M.
    Oncology; 2010 Jul; 78 Suppl 1():17-23. PubMed ID: 20616579
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H, Lok AS.
    Antivir Ther; 2011 Jul; 16(6):787-95. PubMed ID: 21900710
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U.
    Hepatogastroenterology; 2002 Jul; 49(48):1636-8. PubMed ID: 12397752
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
    Sypsa V, Touloumi G, Tassopoulos NC, Ketikoglou I, Vafiadis I, Hatzis G, Tsantoulas D, Akriviadis E, Delladetsima J, Demonakou M, Hatzakis A.
    J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma and hepatitis C in the United States.
    El-Serag HB.
    Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.